Literature DB >> 27811840

Notes from the Field: Rift Valley Fever Response - Kabale District, Uganda, March 2016.

Annabelle de St Maurice, Luke Nyakarahuka, Lawrence Purpura, Elizabeth Ervin, Alex Tumusiime, Stephen Balinandi, Jackson Kayondo, Sophia Mulei, Anne Marion Namutebi, Patrick Tusiime, Steven Wiersma, Stuart Nichol, Pierre Rollin, John Klena, Barbara Knust, Trevor Shoemaker.   

Abstract

On March 9, 2016, a male butcher from Kabale District, Uganda, aged 45 years, reported to the Kabale Regional Referral Hospital with fever, fatigue, and headache associated with black tarry stools and bleeding from the nose. One day later, a student aged 16 years from a different sub-county in Kabale District developed similar symptoms and was admitted to the same hospital. The student also had a history of contact with livestock. Blood specimens collected from both patients were sent for testing for Marburg virus disease, Ebola virus disease, Rift Valley fever (RVF), and Crimean Congo Hemorrhagic fever at the Uganda Virus Research Institute, as part of the viral hemorrhagic fevers surveillance program. The Uganda Virus Research Institute serves as the national viral hemorrhagic fever reference laboratory and hosts the national surveillance program for viral hemorrhagic fevers, in collaboration with the CDC Viral Special Pathogens Branch and the Uganda Ministry of Health.

Entities:  

Mesh:

Year:  2016        PMID: 27811840     DOI: 10.15585/mmwr.mm6543a5

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  16 in total

1.  Impact of enhanced viral haemorrhagic fever surveillance on outbreak detection and response in Uganda.

Authors:  Trevor R Shoemaker; Stephen Balinandi; Alex Tumusiime; Luke Nyakarahuka; Julius Lutwama; Edward Mbidde; Aaron Kofman; John D Klena; Ute Ströher; Pierre E Rollin; Stuart T Nichol
Journal:  Lancet Infect Dis       Date:  2018-03-21       Impact factor: 25.071

Review 2.  Arboviruses in the East African Community partner states: a review of medically important mosquito-borne Arboviruses.

Authors:  Raphael Nyaruaba; Caroline Mwaliko; Matilu Mwau; Samar Mousa; Hongping Wei
Journal:  Pathog Glob Health       Date:  2019-10-30       Impact factor: 2.894

3.  Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats.

Authors:  Rebekah C Kading; Robert M Kityo; Eric C Mossel; Erin M Borland; Teddie Nakayiki; Betty Nalikka; Luke Nyakarahuka; Jeremy P Ledermann; Nicholas A Panella; Amy T Gilbert; Mary B Crabtree; Julian Kerbis Peterhans; Jonathan S Towner; Brian R Amman; Tara K Sealy; Stuart T Nichol; Ann M Powers; Julius J Lutwama; Barry R Miller
Journal:  Infect Ecol Epidemiol       Date:  2018-02-21

4.  Rift Valley Fever: A survey of knowledge, attitudes, and practice of slaughterhouse workers and community members in Kabale District, Uganda.

Authors:  Annabelle de St Maurice; Luke Nyakarahuka; Lawrence Purpura; Elizabeth Ervin; Alex Tumusiime; Stephen Balinandi; Jackson Kyondo; Sophia Mulei; Patrick Tusiime; Craig Manning; Pierre E Rollin; Barbara Knust; Trevor Shoemaker
Journal:  PLoS Negl Trop Dis       Date:  2018-03-05

5.  Methodological aspects of serosurveillance in resource-poor settings.

Authors:  Susanna Sternberg Lewerin; Cecilia Wolff; Charles Masembe; Karl Ståhl; Sofia Boqvist; Mikael Andersson Franko
Journal:  Vet Rec Open       Date:  2018-04-09

Review 6.  Current Status of Rift Valley Fever Vaccine Development.

Authors:  Bonto Faburay; Angelle Desiree LaBeaud; D Scott McVey; William C Wilson; Juergen A Richt
Journal:  Vaccines (Basel)       Date:  2017-09-19

7.  Rift Valley fever seroprevalence and abortion frequency among livestock of Kisoro district, South Western Uganda (2016): a prerequisite for zoonotic infection.

Authors:  Ngabo Herbert Budasha; Jean-Paul Gonzalez; Tesfaalem Tekleghiorghis Sebhatu; Ezama Arnold
Journal:  BMC Vet Res       Date:  2018-09-03       Impact factor: 2.741

8.  Multisectoral prioritization of zoonotic diseases in Uganda, 2017: A One Health perspective.

Authors:  Musa Sekamatte; Vikram Krishnasamy; Lilian Bulage; Christine Kihembo; Noelina Nantima; Fred Monje; Deo Ndumu; Juliet Sentumbwe; Betty Mbolanyi; Robert Aruho; Winyi Kaboyo; David Mutonga; Colin Basler; Sarah Paige; Casey Barton Behravesh
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

9.  Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations.

Authors:  Annabelle de St Maurice; Jessica Harmon; Luke Nyakarahuka; Stephen Balinandi; Alex Tumusiime; Jackson Kyondo; Sophia Mulei; Annemarion Namutebi; Barbara Knust; Trevor Shoemaker; Stuart T Nichol; Anita K McElroy; Christina F Spiropoulou
Journal:  PLoS Negl Trop Dis       Date:  2018-05-04

10.  Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in Southwestern Uganda, 2016.

Authors:  Luke Nyakarahuka; Annabelle de St Maurice; Lawrence Purpura; Elizabeth Ervin; Stephen Balinandi; Alex Tumusiime; Jackson Kyondo; Sophia Mulei; Patrick Tusiime; Julius Lutwama; John D Klena; Shelley Brown; Barbara Knust; Pierre E Rollin; Stuart T Nichol; Trevor R Shoemaker
Journal:  PLoS Negl Trop Dis       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.